Silence Therapeutics, Plc. financial statements, including revenue, expenses, profit, and loss
The total revenue of SLNCF for the last quarter is 2.67 M USD, and it's 21.70% lower compared to the previous quarter. The net income of Q4 23 is -18.35 M USD.